Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

High Serum Vascular Endothelial Growth Factor (VEGF) Level Is An Adverse Prognostic Factor In High Risk Diffuse Large B Cell Lymphoma (DLBCL) Patients Treated with Dose Dense Chemoimmunotherapy and Systemic CNS Prophylaxis Results From a Nordic Phase II Study

Riihuarvi, Sari ; Nyman, Heidi ; Holte, Harald ; Bjorkholm, Magnus ; Fluge, Oystein ; Pedersen, Lars Moller ; Jerkeman, Mats LU ; Eriksson, Mikael LU orcid and Leppa, Sirpa (2010) 52nd Annual Meeting of the American-Society-of-Hematology (ASH) In Blood 116(21). p.1686-1686
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Blood
volume
116
issue
21
pages
1686 - 1686
publisher
American Society of Hematology
conference name
52nd Annual Meeting of the American-Society-of-Hematology (ASH)
conference dates
2010-12-04 - 2010-12-07
external identifiers
  • wos:000285025204561
ISSN
1528-0020
language
English
LU publication?
yes
id
e17554be-75c6-4343-aee3-a0be5553c143 (old id 1918001)
date added to LUP
2016-04-01 10:04:46
date last changed
2025-04-04 14:33:37
@misc{e17554be-75c6-4343-aee3-a0be5553c143,
  author       = {{Riihuarvi, Sari and Nyman, Heidi and Holte, Harald and Bjorkholm, Magnus and Fluge, Oystein and Pedersen, Lars Moller and Jerkeman, Mats and Eriksson, Mikael and Leppa, Sirpa}},
  issn         = {{1528-0020}},
  language     = {{eng}},
  note         = {{Conference Abstract}},
  number       = {{21}},
  pages        = {{1686--1686}},
  publisher    = {{American Society of Hematology}},
  series       = {{Blood}},
  title        = {{High Serum Vascular Endothelial Growth Factor (VEGF) Level Is An Adverse Prognostic Factor In High Risk Diffuse Large B Cell Lymphoma (DLBCL) Patients Treated with Dose Dense Chemoimmunotherapy and Systemic CNS Prophylaxis Results From a Nordic Phase II Study}},
  volume       = {{116}},
  year         = {{2010}},
}